Patent · US Active

Pyrimidinyl tyrosine kinase inhibitors

US10618887B2 · kind B2 · utility

0Cited by

25References

17Claims

0Family size

Assignees

Sunesis Pharmaceuticals, Inc. · US
Biogen MA Inc. · US

Inventors

Brian T. Hopkins · Newton, US
Timothy Chan · Cambridge, US
Tracy J. Jenkins · Watertown, US
Patrick R. Conlon · Wakefield, US
Xiongwei Cai · Arlington, US
Michael Humora · Weston, US
Xianglin Shi · Newton, US
Ross A. Miller · Fanwood, US
Andrew Thompson

Key dates

Filing date	Mar 5, 2018
Grant date	Apr 14, 2020
Priority date	—
Expiry date	Mar 5, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.